---
title: "Innovent licenses IBI355 rights to Spero for up to $1.1bn"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292739699.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-15T09:01:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292739699.md)
  - [en](https://longbridge.com/en/news/292739699.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292739699.md)
---

# Innovent licenses IBI355 rights to Spero for up to $1.1bn

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [SPRO.US](https://longbridge.com/en/quote/SPRO.US.md)

## Related News & Research

- [Spero Therapeutics inks major CD40L and royalty deals](https://longbridge.com/en/news/292732573.md)
- [GS Chain drops GMM deal and seeks new tech-focused acquisition](https://longbridge.com/en/news/294044135.md)
- [Major Forum Markets Stakeholder Makes Bold Multi-Million Dollar Move](https://longbridge.com/en/news/293692069.md)
- [REG - GS Chain PLC - Termination of Potential Acquisition](https://longbridge.com/en/news/294043746.md)
- [Is Sanofi (ENXTPA:SAN) Still Undervalued After Its Eczema Drug Setback?](https://longbridge.com/en/news/293813235.md)